Patients suffering from CAD requiring coronary artery bypass grafting

Prevalent OPG and RANKL Excession in Patients With CAD

Medical University of Graz

Graz Osteoprotegerin as a Risk Factor (GORF) Study

Graz Osteoprotegerin as a Risk Factor (GORF) Study: THE ROLE of OSTEOPROTEGERIN (OPG) and the RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-Kb LIGAND (RANKL) IN PATIENTS REQUIRING SURGERY FOR CORONARY HEART DISEASE

The primary endpoints are the differences between the two groups in serum levels of OPG and RANKL, markers of bone metabolism (osteocalcin [OC], crosslaps [CTX], tartrate resistant acid phosphatase (TRAP5b), 25(OH) vitamin D [Vit D], 1.25(OH) vitamin D, parathormone [iPTH], endocrine parameters related to vascular damage (e.g. aldosterone, renin and cortisol) and bone mineral density.

Daniela Malliga, MD

OA Dr. med. univ.

Medical University of Vienna

Established Carotid Atherosclerosis

Niacin/simvastatin compared to simvastatin alone at 2 doses

Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

Magnetic Resonance Characterization of Carotid Atherosclerotic Plaque in Vivo: Effect of High Density Lipoprotein Elevation on Plaque Morphology

arteriosclerosis/phosphatase

Graz Osteoprotegerin as a Risk Factor (GORF) Study

Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم